Kicking Off 2024: Clinical News, Start-Ups, and More With Ward Lemaire and Dan Hydes

January 9, 2023

New Year, new podcast format! In 2024’s first episode of the Scope of Things, host Deborah Borfitz gives you the latest news from the clinical trials industry, including AI’s role in the creation of digital twins, the obesity epidemic and the drugs intended to combat it, improving diversity in trial candidates, and more. We also have expert advice from Ward Lemaire, VP Head of Data Management and Central Monitoring at J&J Innovative Medicine, and Dan Hydes, Co-Founder and CEO at IgniteData, on SCOPE’s new Startup Pitch Competiton, and how start-up companies can meet multiple demands and needs, direct their limited resources, and keep the innovation train going.

Show Notes

LINKS  

Story in this episode [https://www.clinicalresearchnewsonline.com/scope-of-things/kicking-off-2024-clinical-news-start-ups-and-more-with-ward-lemaire-and-dan-hydes?utm_source=linkedin&utm_medium=social&utm_campaign=IY_podcast_general_promo_20240109]

New Advisory Board

• Ken Getz podcast episode
• Ramita Tandon podcast episode

 
News Roundup

AI and Chatbots

• Belong.Life
• Microsoft’s Trial Matcher
• UF and NVIDIA’s GatorTronGPT
• Genentech’s smart digital assistants

Digital Twins

• Pan-European project simulating stroke treatments

Obesity Clinical Trials

• JAMA paper on unintended consequences of weight-loss drugs 
• FDA’s Ozempic label change
• Physicians in Europe preferentially recommend lifestyle changes

New areas of interest

• Trial begins for Insilico Medicine’s latest AI-discovered drug
• Brain metastases studies in Italy and Spain
• Drug repurposing study in Australia for type 1 diabetes
• Anti-aging TAME trial of Metformin to start

Pharmacy Research Organization RxE2

• Platform for independent community pharmacists launches
• Gerald Finken podcast episode

Amplifying the patient voice

• FDA’s patient- focused drug development initiative
• ‘Evidence-generating Commons’ for rare disease policymaking in Japan

Software as a Medical Device

• Close to one-quarter of SaMD approvals for AI-based software

Guests

• Dan Hydes, CEO and Cofounder of IgniteData
• Ward Lemaire, Head of Data Management and Central Monitoring at J&J Innovative Medicine
• Story about the Start Up Pitch Contest at SCOPE
• SCOPE Summit in Orlando, February 11-14

Ward Lemaire, VP Head of Data Management and Central Monitoring J&J Innovative Medicine
20 years of experience in Data Management related functions in the Pharmaceutical Industry, lived and worked in 3 different continents (Belgium, China and US). Board of Trustee of SCDM (Society for Clinical Data Management).

Dan Hydes, Co-Founder and CEO, IgniteData
Dan Hydes led the critical work shaping and refining the value proposition, commercial model and global scaleup strategy for Archer, IgniteData’s EHR-to-EDC system-agnostic data transfer technology and has responsibility for the strategy and commercial areas at IgniteData. He previously co-founded a business that successfully ran projects ranging from bringing together groups of clinicians for expert symposiums to recruitment feasibility for clinical trials. Dan has also led large commercial teams for global media organizations.